Procurement Governance Is Replacing Decentralized Buying Across Health Systems
Healthcare organizations are running into a financial problem that is not driven by a single vendor contract or a temporary price spike. The deeper issue is fragmented indirect spend, where departments, facilities, and service lines buy non-clinical supplies through online retailers, local vendors, and legacy purchasing channels with little enterprise oversight. Over time, that pattern produces duplicate products, inconsistent pricing, and weak visibility into what the system is actually spending.
The response now taking shape is a move toward procurement governance. Health systems are shifting away from decentralized buying and toward models that standardize purchasing rules, consolidate vendors, and restore accountability across the enterprise. The goal is not only to spend less. It is to regain control over purchasing behavior before fragmentation hardens into the operating norm.
A single health system can carry dozens of similar items under different stock keeping units, or SKUs, each with its own price point and supplier relationship. That duplication makes it harder to compare costs, enforce approved products, and identify waste. It also weakens the system’s ability to negotiate from a position of strength, because purchasing volume is dispersed across too many channels to present a unified picture.
Why Indirect Spend Has Become a Control Problem
Indirect categories such as facilities supplies, office essentials, breakroom products, furniture, and environmental services inputs do not always attract the same scrutiny as pharmaceuticals or medical devices. Yet these categories shape daily operations and influence whether staff can work efficiently. When a health system allows those purchases to sprawl across multiple sites and uncoordinated ordering paths, the result is predictable: redundant SKUs, vendor duplication, and price variability for identical items.
That fragmentation is more than administrative clutter. It reduces enterprise visibility and makes it difficult to enforce purchasing policy. In a multi-site organization, one facility may pay more for the same product than another, while central leadership lacks a clean view of the difference. Procurement then becomes reactive, with staff solving immediate supply needs instead of operating within a controlled system.
John Geurin, senior vice president of Vertical Markets for Healthcare at Staples Business, framed the change in direct terms: health systems are moving from fragmented purchasing to governed, standardized procurement that improves visibility, consistency, and control across the enterprise.
Standardization Is Now the Core Operating Principle
The most effective response centers on standardization. Health systems are defining approved products, creating consistent purchasing rules, consolidating vendors, and tightening reporting structures. Those steps do not eliminate local needs, but they reduce the number of ad hoc decisions made outside the system’s controls.
Procurement is no longer being treated as a purely transactional function. It is becoming an enterprise management process, one where consistency carries as much weight as unit price. A leaner assortment of approved products can reduce SKU proliferation and simplify ordering across multiple locations. It also improves data quality, since a smaller, normalized catalog is easier to track, compare, and audit.
Geurin described the operational priority plainly: successful health systems focus on control and consistency while simplifying execution rather than layering on unnecessary complexity. That approach fits the reality of large healthcare networks, where every added purchasing exception creates another place for leakage, confusion, and noncompliance.
Reliability Matters as Much as Price
Reliability has emerged as a procurement requirement in its own right. When supplies are delayed or fulfillment varies by site, the burden falls on environmental services teams, facilities staff, and administrative personnel who must keep operations moving despite inconsistent sourcing. Standardized procurement improves product availability and ordering consistency, and it aligns fulfillment more closely across locations.
The bedside effect may be indirect, but it is real. Delays in basic supplies create friction that ripples through staffing workflows and daily operations. A system that cannot reliably supply its own non-clinical essentials is forced to absorb avoidable disruption in places that are already under pressure.
One sentence captures the operational shift: reliability is now being judged alongside cost, not after it.
Data Readiness Comes Before Artificial Intelligence
Artificial intelligence is moving into procurement, but the data problem has to be solved first. Fragmented buying creates inconsistent SKU structures, siloed vendor records, and incomplete spend visibility. In that environment, analytics tools cannot generate dependable insights because the underlying data is too messy to support them.
The 2026 State of Healthcare Procurement, developed with The Advisory Board, reinforces that governance and data standardization are prerequisites for effective AI use. The logic is straightforward. AI can only optimize what the organization has already structured in a consistent way. If product catalogs are not standardized and vendor records are scattered, the technology will amplify confusion rather than remove it.
Leading organizations are therefore prioritizing standardized procurement catalogs, enterprise purchasing policies, normalized SKU and vendor data, and centralized workflows before layering in automation. This sequence matters because procurement technology is only as strong as the architecture beneath it. Systems that rush to AI without first cleaning up their data will spend time automating disorder.
The Strategic Value of Indirect Spend
Indirect spend has often been treated as a back-office detail, but that framing is giving way to a more strategic view. When managed well, these categories can improve budget predictability, support operational clarity, and reduce waste across the enterprise. When managed poorly, they become a persistent source of drift and hidden cost.
The shift toward governance signals a broader operational correction. Health systems are not simply trimming expenses; they are redesigning the rules that determine how purchasing happens. That includes vendor rationalization, stronger enforcement of approved assortments, and better reporting structures that make it easier to see where money is going and why.
The most immediate benefit is control. Once purchasing becomes standardized, leadership can compare prices more accurately, reduce duplication, and make vendor relationships easier to manage. Over time, those gains can support a more disciplined operating model, especially in systems where decentralized buying has been tolerated for years.
What remains unresolved is how quickly organizations can convert governance principles into durable day-to-day practice. Fragmentation builds quietly, and reversing it requires more than policy language. It demands consistent enforcement, cleaner data, and enough organizational discipline to keep the system from drifting back toward the same purchasing habits that created the problem in the first place.